Bristol-Myers Squibb Stock
Price
Target price
€45.97
€45.97
0.420%
0.19
0.420%
€65.03
14:41 / Tradegate
WKN: 850501 / Symbol: BMY / Name: Bristol-Myers / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Bristol-Myers Squibb Stock
The Bristol-Myers Squibb stock is trending slightly upwards today, with an increase of €0.19 (0.420%) compared to yesterday's price.
Currently there is a rather positive sentiment for Bristol-Myers Squibb with 10 Buy predictions and 3 Sell predictions.
As a result the target price of 65 € shows a positive potential of 41.4% compared to the current price of 45.97 € for Bristol-Myers Squibb.
For the coming years our community has positive and negative things to say abot the Bristol-Myers Squibb stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Business model" there were negative voices in the community.
Pros and Cons of Bristol-Myers Squibb in the next few years
Pros
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bristol-Myers Squibb vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bristol-Myers Squibb | 0.420% | 0.748% | -4.724% | -28.692% | -1.336% | -16.062% | 13.345% |
| Pfizer Inc. | 0.140% | 1.632% | -2.959% | -32.787% | -5.747% | -23.017% | -26.256% |
| Elanco Animal Health Inc. | -0.100% | -2.133% | -14.126% | 38.458% | -7.012% | -51.497% | - |
| Biogen Inc. | 6.990% | -1.878% | -10.831% | -32.623% | -23.537% | -16.970% | -12.476% |
Comments
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at Bank of America Co. from $72.00 to $68.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BMY provided by MarketBeat
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $81.00 to $69.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BMY provided by MarketBeat
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at Morgan Stanley from $56.00 to $50.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for BMY provided by MarketBeat
